The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs.
This report contains market size and forecasts of Artificial Vital Organs and Medical Bionics in global, including the following market information:
Global Artificial Vital Organs and Medical Bionics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artificial Vital Organs and Medical Bionics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Artificial Vital Organs and Medical Bionics companies in 2021 (%)
The global Artificial Vital Organs and Medical Bionics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Artificial Vital Organs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Vital Organs and Medical Bionics include Abbott, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter, Cyberonics, Inc., Edwards, Ekso Bionics, Roche and Fresenius, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Vital Organs and Medical Bionics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Vital Organs and Medical Bionics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Vital Organs and Medical Bionics Market Segment Percentages, by Type, 2021 (%)
Artificial Vital Organs
Bionics
Global Artificial Vital Organs and Medical Bionics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Vital Organs and Medical Bionics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Artificial Vital Organs and Medical Bionics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Artificial Vital Organs and Medical Bionics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Vital Organs and Medical Bionics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artificial Vital Organs and Medical Bionics revenues share in global market, 2021 (%)
Key companies Artificial Vital Organs and Medical Bionics sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Artificial Vital Organs and Medical Bionics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter
Cyberonics, Inc.
Edwards
Ekso Bionics
Roche
Fresenius
Baxter International
Iwalk
Jarvik Heart
Medtronic
Micromed Cardiovascular
Nikkiso
Ossur Hf
Ottobock
Second Sight Medical Products, Inc.
Syncardia Systems, Inc.
Thoratec Corporation
Touch Bionics, Inc.
Vital Therapies, Inc.
WorldHeart Corporation